Michael Severino
CIK: 0001609447
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jul 28, 2026SRPT
Sarepta Therapeutics, Inc.
Award(A)Direct756.1K shares- - May 7, 2026AVTR
Avantor, Inc.
Award(A)Direct25.3K shares- - Mar 6, 2026VTRS
Viatris Inc
Exercise(M)Direct919 shares- - Mar 6, 2026VTRS
Viatris Inc
Exercise(M)Direct25.1K shares- - Mar 6, 2026VTRS
Viatris Inc
Award(A)DirectRestricted Stock Units
15.9K shares- - May 12, 2025VTRS
Viatris Inc
Award(A)DirectRestricted Stock Units
25.1K shares- - May 8, 2025AVTR
Avantor, Inc.
Award(A)Direct17.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 28, 2026 |  SRPT Sarepta Therapeutics, Inc. | Award(A) | 756,104 | - | $0 | Direct |
| May 7, 2026 |  AVTR Avantor, Inc. | Award(A) | 25,270 | - | $0 | Direct |
| Mar 6, 2026 |  VTRS Viatris Inc | Exercise(M) | 919 | - | $0 | Direct |
| Mar 6, 2026 | VTRS Viatris Inc | Exercise(M) | 25,112 | - | $0 | Direct |
| Mar 6, 2026 | VTRS Viatris Inc | Award(A) Restricted Stock Units | 15,890 | - | - | Direct |
| May 12, 2025 | VTRS Viatris Inc | Award(A) Restricted Stock Units | 25,112 | - | - | Direct |
| May 8, 2025 | AVTR Avantor, Inc. | Award(A) | 17,100 | - | - | Direct |
1-7 of 7 transactions
About SEVERINO MICHAEL
SEVERINO MICHAEL (SEC CIK 0001609447) files insider reports with the SEC as Chief Executive Officer of Sarepta Therapeutics, Inc. (SRPT), Director of Avantor, Inc. (AVTR) and Director of Viatris Inc (VTRS).
Signal8 holds 7 ownership filings by SEVERINO MICHAEL (2 Form 3, 5 Form 4), filed between May 12, 2025 and Jul 29, 2026. Those filings report 7 transactions, from May 8, 2025 to Jul 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SEVERINO MICHAEL's filings is in MA.
Recent filings by SEVERINO MICHAEL
- Jul 28, 2026: Grant or award of SRPT shares (Form 4, code A).
- May 7, 2026: Grant or award of AVTR shares (Form 4, code A).
- Mar 6, 2026: Option exercises of VTRS shares (2 lines, Form 4, code M).
- Mar 6, 2026: Grant or award of VTRS derivative securities (Form 4, code A).
- May 12, 2025: Grant or award of VTRS derivative securities (Form 4, code A).
Other insiders filing for Sarepta Therapeutics, Inc. (SRPT)
- Wong Ryan Ho-Yan, Chief Financial Officer
- Estepan Ian Michael, Chief Operating Officer
- Rothfuss Cristin, EVP, General Counsel
- Rodino-Klapac Louise, President, R&D and Tech Ops
- Boor Kathryn Jean, Director
- Mayo Stephen, Director